Alpha Tau - DRTS Net earnings per one share for the last twelve months

Alpha Tau Corp (DRTS) - corporate logo

Alpha Tau Medical Ltd. (DRTS) creates unique alpha-radiation systems, generating revenue through the supply of high-cost disposable radioactive capsules for clinics. The company is developing an innovative therapy method via strategic alliances with global oncology centers. This chart illustrates the asset's market value, showing an EPS (TTM) of -115.60. Manufacturing processes strictly comply with nuclear regulations regarding the safe disposal of hazardous isotopic waste.

Alpha Tau Medical Ltd. (DRTS): Net earnings per share for the last 12 months from 02/11/2024 to 11/17/2026

Financial and market metric breakdowns for Alpha Tau Medical Ltd. (DRTS)

- share price and consensus valuation forecast:
Initial company analysis:DRTS, Alpha Tau Medical Ltd
Original product of Alpha Tau Corp

Analyzing the assets of Alpha Tau Medical Ltd. (DRTS) requires an assessment of net income per share dynamics. The current state of annual EPS TTM growth reflects the percentage change in earnings over the last twelve months, comparing actual results against market expectations. For a company implementing innovations in oncology centers through clinical partnerships, this indicator confirms the effectiveness of technology commercialization. A positive trend signals growth in capitalization and business resilience.